Written Question·Department of Health and Social Care·UIN 83989
Rare Diseases: Drugs
Tabled: 21 October 2025
Answered: 6 November 2025
Question
John Milne
Liberal Democrat — Horsham
To ask the Secretary of State for Health and Social Care, how many of the commercial arrangements made by NHS England with marketing authorisation holders between January 2020 and September 2025 involving indication-specific pricing were for indications f
Answer
Dr Zubir AhmedBetween January 2020 and September 2025, NHS England entered into 75 commercial arrangements involving indication-specific pricing. Of these, eight of the commercial agreements have involved indication-specific pricing for rare non-oncology conditions, an...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 83989) →